Franklin Resources’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-9,630
Closed -$7.45M – 1999
2020
Q4
$7.45M Sell
9,630
-3,286
-25% -$2.59M ﹤0.01% 1015
2020
Q3
$12.8M Hold
12,916
– – 0.01% 857
2020
Q2
$14.7M Buy
12,916
+6,875
+114% +$6.92M 0.01% 806
2020
Q1
$4.9M Sell
6,041
-1,443
-19% -$1.51M ﹤0.01% 932
2019
Q4
$9.36M Sell
7,484
-329
-4% -$530K ﹤0.01% 906
2019
Q3
$10.5M Hold
7,813
– – 0.01% 876
2019
Q2
$13.9M Hold
7,813
– – 0.01% 831
2019
Q1
$13.5M Buy
+7,813
New +$13M 0.01% 818

Other funds holding GOSS

Franklin Resources's GOSS Position: Q1 2021 in Review

Franklin Resources sold out of Gossamer Bio (GOSS) in Q1 2021, closing a stake of 9,630 shares — an estimated $7.45M sold.

Franklin Resources first reported a position in GOSS in Q1 2019 and held it in 8 quarters. The position peaked at $14.7M in Q2 2020. 123 funds tracked by Wall St. Rank hold GOSS as of Q1 2021.

  • Franklin Resources reported no remaining Gossamer Bio position as of Q1 2021 after selling out during the quarter.
  • Franklin Resources sold 9,630 Gossamer Bio shares in Q1 2021, an estimated $7.45M.
  • Franklin Resources first reported a position in Gossamer Bio in Q1 2019 and held it in 8 quarters.
  • Franklin Resources's Gossamer Bio position peaked at $14.7M in Q2 2020.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2021.

Based on Franklin Resources's 13F filing for Q1 2021, filed 13 May 2021.